TY - JOUR
T1 - Factors associated with exacerbation of newly diagnosed mild ulcerative colitis based on a nationwide registry in Japan
AU - Kuwahara, Erika
AU - Murakami, Yoshitaka
AU - Nakamura, Takahiro
AU - Inoue, Nagamu
AU - Nagahori, Masakazu
AU - Matsui, Toshiyuki
AU - Watanabe, Mamoru
AU - Suzuki, Yasuo
AU - Nishiwaki, Yuji
N1 - Funding Information:
The members of this Japanese IBD research group were organized by the Ministry of Health, Labour and Welfare of Japan. This work was supported in part by Health and Labour Sciences Research Grants for research on intractable diseases from the Japanese Ministry of Health, Labour and Welfare. We would like to express our gratitude to a number of physicians and surgeons in Japan who were involved in UC treatment and who prepared the registration forms.
Funding Information:
YS has received lecture honoraria from Mitsubishi Tanabe Pharma Corporation, ZERIA Pharmaceutical Co., Ltd., and AbbVie GK. TM has received research grants from Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation., AJINOMOTO PHARMACEUTICALS Co., Ltd., ZERIA Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., and JIMRO Co., Ltd., and has received lecture fees from Eisai Co., Ltd. MN has received lecture honoraria from Mitsubishi Tanabe Pharma Corporation, Eisai Co., and AbbVie GK. All remaining authors declare that they have no competing interests.
Publisher Copyright:
© 2016, Japanese Society of Gastroenterology.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Background: The exacerbation of disease in patients with ulcerative colitis (UC) can greatly affect quality of life and can impose economic burdens. In Japan, a large nationwide registry for the medical reimbursement of UC patients has existed since 1975. We aimed to examine factors associated with UC exacerbation among patients newly diagnosed with mild UC using electronic data from the registry. Methods: We retrospectively reviewed the clinical data of patients (n = 8120) newly diagnosed with mild UC between 2003 and 2011, and examined the association of patient background, medications, clinical symptoms and laboratory data, and pathological findings with exacerbation of UC, using the Cox proportional hazards model. Results: The incidence of UC exacerbation was 94.6 per 1000 person-years (mean follow-up of 2.1 years). We found that male sex, age <17 years, an extensive lesion (left-sided colitis or pancolitis), overweight or obesity, hematochezia (mild or moderate-to-severe), mushy stools, frequency of bowel movements, and crypt architectural distortion were positively associated with UC exacerbation. On the other hand, age >40 years, high hemoglobin concentration, and high serum albumin levels were inversely associated with UC exacerbation among patients with mild UC in Japan. Conclusion: Using data from the Japanese nationwide registry, we identified several factors, including body mass index and pathological findings, associated with disease exacerbation among patients with newly diagnosed mild UC. Our findings may lead to earlier recognition of exacerbation in patients with mild UC, thus enabling optimal care.
AB - Background: The exacerbation of disease in patients with ulcerative colitis (UC) can greatly affect quality of life and can impose economic burdens. In Japan, a large nationwide registry for the medical reimbursement of UC patients has existed since 1975. We aimed to examine factors associated with UC exacerbation among patients newly diagnosed with mild UC using electronic data from the registry. Methods: We retrospectively reviewed the clinical data of patients (n = 8120) newly diagnosed with mild UC between 2003 and 2011, and examined the association of patient background, medications, clinical symptoms and laboratory data, and pathological findings with exacerbation of UC, using the Cox proportional hazards model. Results: The incidence of UC exacerbation was 94.6 per 1000 person-years (mean follow-up of 2.1 years). We found that male sex, age <17 years, an extensive lesion (left-sided colitis or pancolitis), overweight or obesity, hematochezia (mild or moderate-to-severe), mushy stools, frequency of bowel movements, and crypt architectural distortion were positively associated with UC exacerbation. On the other hand, age >40 years, high hemoglobin concentration, and high serum albumin levels were inversely associated with UC exacerbation among patients with mild UC in Japan. Conclusion: Using data from the Japanese nationwide registry, we identified several factors, including body mass index and pathological findings, associated with disease exacerbation among patients with newly diagnosed mild UC. Our findings may lead to earlier recognition of exacerbation in patients with mild UC, thus enabling optimal care.
KW - Exacerbation
KW - Severity
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=84963690419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963690419&partnerID=8YFLogxK
U2 - 10.1007/s00535-016-1209-x
DO - 10.1007/s00535-016-1209-x
M3 - Article
C2 - 27075755
AN - SCOPUS:84963690419
SN - 0944-1174
VL - 52
SP - 185
EP - 193
JO - Journal of gastroenterology
JF - Journal of gastroenterology
IS - 2
ER -